BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20132223)

  • 1. Histone acetylation and steroid receptor coactivator expression during clofibrate-induced rat hepatocarcinogenesis.
    Asano J; Kudo T; Shimizu T; Fan Y; Nanashima N; Yamana D; Miura T; Yamada T; Tsuchida S
    Cancer Sci; 2010 Apr; 101(4):869-75. PubMed ID: 20132223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different susceptibility to peroxisome proliferator-induced hepatocarcinogenesis in rats with polymorphic glutathione transferase genes.
    Kudo T; Asano J; Shimizu T; Nanashima N; Fan Y; Akita M; Ookawa K; Hayakari M; Yokoyama Y; Suto K; Tsuchida S
    Cancer Sci; 2006 Aug; 97(8):703-9. PubMed ID: 16800819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease of hepatic stellate cells in rats with enhanced sensitivity to clofibrate-induced hepatocarcinogenesis.
    Yamana D; Shimizu T; Fan Y; Miura T; Nanashima N; Yamada T; Hakamada K; Tsuchida S
    Cancer Sci; 2011 Apr; 102(4):735-41. PubMed ID: 21214675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
    Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ
    Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione S-transferase A4 is a positive marker for rat hepatic foci induced by clofibrate and genotoxic carcinogens.
    Shimizu T; Fan Y; Yamana D; Miura T; Nanashima N; Yamada T; Tsuchida S
    Cancer Sci; 2010 May; 101(5):1093-8. PubMed ID: 20180811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor alpha activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat.
    Banks T; Oyekan A
    J Hypertens; 2008 Mar; 26(3):468-77. PubMed ID: 18300857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
    Hays T; Rusyn I; Burns AM; Kennett MJ; Ward JM; Gonzalez FJ; Peters JM
    Carcinogenesis; 2005 Jan; 26(1):219-27. PubMed ID: 15447978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of peroxisome proliferator-activated receptor alpha (PPARalpha)-related enzymes by di(2-ethylhexyl) phthalate (DEHP) treatment in mice and rats, but not marmosets.
    Ito Y; Yamanoshita O; Kurata Y; Kamijima M; Aoyama T; Nakajima T
    Arch Toxicol; 2007 Mar; 81(3):219-26. PubMed ID: 16937134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of rat oval cells after activation of peroxisome proliferator-activated receptor alpha43.
    Kaplanski C; Pauley CJ; Griffiths TG; Kawabata TT; Ledwith BJ
    Cancer Res; 2000 Feb; 60(3):580-7. PubMed ID: 10676640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the peroxisome proliferator-activated receptor-alpha agonists clofibrate and fish oil on hepatic fatty acid metabolism in weaned dairy calves.
    Litherland NB; Bionaz M; Wallace RL; Loor JJ; Drackley JK
    J Dairy Sci; 2010 Jun; 93(6):2404-18. PubMed ID: 20494149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome-proliferator-activated receptors as physiological sensors of fatty acid metabolism: molecular regulation in peroxisomes.
    Latruffe N; Cherkaoui Malki M; Nicolas-Frances V; Jannin B; Clemencet MC; Hansmannel F; Passilly-Degrace P; Berlot JP
    Biochem Soc Trans; 2001 May; 29(Pt 2):305-9. PubMed ID: 11356172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human health risk assessment for peroxisome proliferators: more than 30 years of research.
    Fidaleo M
    Exp Toxicol Pathol; 2009 May; 61(3):215-21. PubMed ID: 18926675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPARalpha)-regulated genes and is ameliorated by PPARalpha activation.
    Nanji AA; Dannenberg AJ; Jokelainen K; Bass NM
    J Pharmacol Exp Ther; 2004 Jul; 310(1):417-24. PubMed ID: 15016835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of the expression of the peroxisome proliferator-activated receptor alpha (PPARalpha) by clofibrate in jerboa tissues.
    Amsaguine-Safir S; Bianchi A; Collet P; Huin-Schohn C; Jeanvoine A; Bécuwe P; Krémarik-Bouillaud P; Domenjoud L; Keller JM; Schohn H; Dauça M
    Microsc Res Tech; 2003 Jun; 61(2):185-90. PubMed ID: 12740825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential induction of genes in liver and brown adipose tissue regulated by peroxisome proliferator-activated receptor-alpha during fasting and cold exposure in acyl-CoA dehydrogenase-deficient mice.
    Goetzman ES; Tian L; Wood PA
    Mol Genet Metab; 2005 Jan; 84(1):39-47. PubMed ID: 15639194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
    Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
    Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Less extrahepatic induction of fatty acid beta-oxidation enzymes by PPAR alpha.
    Cook WS; Yeldandi AV; Rao MS; Hashimoto T; Reddy JK
    Biochem Biophys Res Commun; 2000 Nov; 278(1):250-7. PubMed ID: 11071880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level.
    Lee GY; Kim NH; Zhao ZS; Cha BS; Kim YS
    Biochem J; 2004 Mar; 378(Pt 3):983-90. PubMed ID: 14641110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver.
    Cariello NF; Romach EH; Colton HM; Ni H; Yoon L; Falls JG; Casey W; Creech D; Anderson SP; Benavides GR; Hoivik DJ; Brown R; Miller RT
    Toxicol Sci; 2005 Nov; 88(1):250-64. PubMed ID: 16081524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the hepatic fatty acid pool in peroxisomal 3-ketoacyl-CoA thiolase B-null mice exposed to the selective PPARalpha agonist Wy14,643.
    Arnauld S; Fidaleo M; Clémencet MC; Chevillard G; Athias A; Gresti J; Wanders RJ; Latruffe N; Nicolas-Francès V; Mandard S
    Biochimie; 2009; 91(11-12):1376-86. PubMed ID: 19772884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.